The Quantellect read.As of Nov 19, 2026, 12 active firms cover American Healthcare REIT, Inc: 12 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $55.00 to $70.00, so the covering firms are broadly aligned. The average target of $62.17 sits 6% above the current $58.55. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 20% this year and 10% next, consensus EPS building from about $0.19 next quarter toward $0.90 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Buy
Strong Buy18%
Buy1192%
Neutral00%
Sell00%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$62.17
+6.2% upside
Average target across 12 active firms as of Nov 19, 2026 vs $58.55 current
Highest Target$70.00
Average Target$62.17
Lowest Target$55.00
Detailed analyst forecasts for AHR
Showing 1–12 of 12 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 12 of 12 active firms rate AHR a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
AHR EPS & revenue forecast
EPS · NEXT QUARTER
$0.19
Range $0.19 – $0.19 · 1 analysts · +37% YoY
Next period, 1 analysts expect American Healthcare REIT, Inc. to earn $0.19 a share (range $0.19 – $0.19), versus $0.14 a year earlier. Full-year consensus is $0.63, growing to $0.90 the year after.
REVENUE · NEXT QUARTER
$824.7M
Range $745.6M – $939.7M · 1 analysts · +20% YoY
Revenue is expected to reach $824.7M (range $745.6M – $939.7M), +20.0% year-over-year. Full-year consensus is $2.8B, rising to $3.4B next year.
Top analysts covering American Healthcare REIT, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AHR.
#1
Nicholas Yulico
Scotiabank · Rank #77
Buy
$62.00+5.9% to target
Overall win rate
53%
+ Follow
#2
Richard Hightower
Barclays · Rank #184
Buy
$60.00+2.5% to target
Overall win rate
45%
+ Follow
#3
Michael Lewis
Truist Securities · Rank #243
Buy
$61.00+4.2% to target
Overall win rate
43%
+ Follow
#4
Aaron Hecht
JMP Securities · Rank #299
Buy
$65.00+11.0% to target
Overall win rate
47%
+ Follow
#5
AW
Austin Wurschmidt
KeyBanc
Buy
$68.00+16.1% to target
Coverage
—
+ Follow
AHR stock forecast FAQ
What is AHR's average 12-month price target?+
The 12 active firms with a live target average $62.17 for American Healthcare REIT, Inc. over the next 12 months, ranging from a $70.00 high to a $55.00 low, as of Nov 19, 2026.
Is AHR stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 12 active firms as of Nov 19, 2026, 12 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for AHR?+
The Street-high target is $70.00 (Compass Point), and the Street-low is $55.00 (BMO Capital). The average of all 12 active-firm targets is $62.17.
How many active Wall Street firms cover AHR?+
12 active firms have a recognized rating on American Healthcare REIT, Inc. as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering AHR?+
Among analysts who currently cover AHR, Nicholas Yulico of Scotiabank has the strongest overall Quantellect track record (Rank #77). Their current call is Buy with a $62.00 target.
What is American Healthcare REIT, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.19 per share (range $0.19 – $0.19) across 1 analysts. Full-year EPS is projected at $0.63, rising to $0.90 the following year.
How much revenue is American Healthcare REIT, Inc. expected to report next quarter?+
Consensus revenue is $824.7M (range $745.6M – $939.7M). Full-year revenue is projected at $2.8B, growing to $3.4B next year.
Have analysts been upgrading or downgrading AHR lately?+
As of Nov 19, 2026, 12 of 12 active firms rate AHR a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AHR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.